Novartis buys Blackstone-owned biopharma firm Anthos for $3b

Novartis buys Blackstone-owned biopharma firm Anthos for $3b

Photo: Pixabay

11 February, 2025

Blackstone Novartis

Printed by Unregistered user on Tue, 29 Jul 2025 05:03:28 GMT

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief

Subscribe to Newsletter

You may also like

Macquarie, Blackstone to launch private infrastructure trusts in Japan

Blackstone stays firm on data centre investments despite DeepSeek turmoil

Read more from World

China’s FountainVest to buy major stake in Italy’s EuroGroup Laminations

Climate Tech & ESG

Brazil in talks with TPG, Brookfield to raise $4b for climate finance